🔗 Share this article TikTok Influencers Fueling Unofficial Market for Unlicensed Weight-Loss Medication A shadow economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations. Investigational Drug Acquiring Traction Via Social Media The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers. Thriving Trade on Messaging Platforms Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases. Understanding The Experimental Drug Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic. Healthcare Experts Voice Concerns However, physicians and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source. Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro. Regulatory Status and Enforcement Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012. Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment. Platform Response and Content Elimination According to TikTok, the service has taken down violative material and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in strengthening compliance measures. Online Trading Activities Research also found groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, populated with images of weight loss, positive testimonials and step-by-step instructions for mixing or administering at residence. Within moments of entering one community, a vendor posted WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage. Product Details and Costs Within these communities, posts display black plastic parcels with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.” Customers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”. Platform Moderation and Safety Actions A spokesperson for Telegram stated it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Warnings “People are injecting substances they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service. A medical professional of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained. Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.” Manufacturer Statement A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant health risks”.